Literature DB >> 18692907

Development of ELISAs for the measurement of IgM and IgG subclasses in sera from llamas (Lama glama) and assessment of the humoral immune response against different antigens.

Emilio A De Simone1, Natalia Saccodossi, Alejandro Ferrari, Juliana Leoni.   

Abstract

Members of the Camelidae family possess a functional class of antibodies devoid of light chains (known as heavy chain antibodies, HCAbs). Three IgG isotypes have been identified (IgG(1), IgG(2) and IgG(3)); IgG(2) and IgG(3) are HCAbs whereas the IgG(1) has the conventional structure. Different subtypes of IgG(1) (IgG(1a) and IgG(1b)) and IgG(2) (IgG(2a), IgG(2b) and IgG(2c)) have been classified according to variations in the amino acids sequence of the hinge region. The single variable domain of HCAbs has been referred as VHH. Until now, the relative amount of each subclass has been inferred, but the lack of highly specific antibodies against HCAbs has been a limitation for their quantification. In a previous work, we produced specific polyclonal antibodies against IgG(2a), IgG(2b), IgG(2c) and IgG(3) by immunizing rabbits with synthetic and recombinant peptides corresponding to their hinge region. In this work we produced specific antisera against llama IgM and IgG(1). The anti-IgG(1) serum was obtained by immunizing rabbits with a recombinant fusion protein formed by GST fused to the CH(1) domain of the IgG(1). The anti-IgM serum was obtained by immunizing rabbits with IgM heavy chain. All these antisera were useful for the development of ELISAs for the measurement of IgM, total IgG and IgG subclasses. Sera from llamas (n=20) analyzed by ELISA gave the following values of immunoglobulins: IgG(1)=6.168+/-1.628 mg/ml; IgG(2)=0.684+/-0.310 mg/ml; IgG(3)=1.232+/-0.410 mg/ml; total IgG=8.933+/-1.815 mg/ml and IgM=1.027+/-0.308 mg/ml. These results indicate that HCAbs represent almost 25% of total IgG and the IgG(3) subtype is the predominant HCAb. We also analyzed the primary humoral immune response after immunization llamas with different antigens (BSA, BSA-DNP and dextran). Although it has been described that a few VHH clones are very efficient in the interaction with haptens, in this case the response against DNP was characterized by a delayed appearance of HCAbs in comparison with that of IgG(1). No anti-dextran response was observed in any of the isotypes analyzed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18692907     DOI: 10.1016/j.vetimm.2008.06.015

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  6 in total

1.  Structure and specificity of several triclocarban-binding single domain camelid antibody fragments.

Authors:  Sofia Tabares-da Rosa; Linda A Wogulis; Mark D Wogulis; Gualberto González-Sapienza; David K Wilson
Journal:  J Mol Recognit       Date:  2018-07-23       Impact factor: 2.137

2.  Evaluation of antidiphtheria toxin nanobodies.

Authors:  Ghada H Shaker
Journal:  Nanotechnol Sci Appl       Date:  2010-06-17

3.  Construction of Immunomagnetic Particles with High Stability in Stringent Conditions by Site-Directed Immobilization of Multivalent Nanobodies onto Bacterial Magnetic Particles for the Environmental Detection of Tetrabromobisphenol-A.

Authors:  Jinxin He; Shijiao Ma; Sha Wu; Junjie Xu; Jiesheng Tian; Ji Li; Shirley J Gee; Bruce D Hammock; Qing X Li; Ting Xu
Journal:  Anal Chem       Date:  2019-12-16       Impact factor: 8.008

Review 4.  Single-Domain Antibodies As Versatile Affinity Reagents for Analytical and Diagnostic Applications.

Authors:  Gualberto Gonzalez-Sapienza; Martín A Rossotti; Sofía Tabares-da Rosa
Journal:  Front Immunol       Date:  2017-08-21       Impact factor: 7.561

5.  Camelid Single-Domain Antibodies: Historical Perspective and Future Outlook.

Authors:  Mehdi Arbabi-Ghahroudi
Journal:  Front Immunol       Date:  2017-11-20       Impact factor: 7.561

Review 6.  Perspective on therapeutic and diagnostic potential of camel nanobodies for coronavirus disease-19 (COVID-19).

Authors:  Salma Bessalah; Samira Jebahi; Naceur Mejri; Imed Salhi; Touhami Khorchani; Mohamed Hammadi
Journal:  3 Biotech       Date:  2021-01-22       Impact factor: 2.406

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.